Walvax Biotechnology Hits Day Low of CNY 11.48 Amid Price Pressure

Walvax Biotechnology Co., Ltd. experienced a significant decline today, with the stock dropping by 6.47% to touch an intraday low of CNY 11.48. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Walvax has seen a decrease of 4.72%, while its monthly performance reflects a decline of 2.34%. Year-to-date, the stock has managed a modest gain of 7.24%, although it has underperformed over the longer term, with a staggering 68.04% drop over the past three years and a 73.85% decline over five years. The company's financial metrics indicate ongoing challenges, with net sales growing at an annual rate of only 4.90% and operating profit showing a significant negative trend. Additionally, Walvax has reported negative results for the last seven consecutive quarters, highlighting persistent difficulties in achieving profitability. The stock's current high dividend yield of 0.34% may not offset the risks associated with its performance and market position.